Cellcraft is a B2B biotechnology startup focused on revolutionizing biomanufacturing through intelligent infrastructure. Their flagship platform, Cellcraft IQ, leverages machine learning and real-time control to enhance bioreactor performance, enabling adaptive optimization, predictive monitoring, and autonomous process tuning. By transforming bioprocessing into a data-driven engineering discipline, Cellcraft supports reliable and scalable production in the biopharma and cultivated meat sectors. The company is backed by the University of Cambridge Judge Business School and leading international venture capital investors, positioning itself at the forefront of innovation in the intersection of machine learning, biology, and industrial automation.